Use of bisphosphonates in prostate cancer: Current status

Bisphosphonates are a relatively newer class of drugs which have been used for the prevention of skeletal related complications of age related osteoporosis or metastatic disease from carcinoma breast or multiple myeloma. Their role in the management of prostate cancer is still under evolution. We he...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayyar, Rishi, Gupta, Narmada P.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2007
Materias:
Symposium
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721496/
https://www.ncbi.nlm.nih.gov/pubmed/19675763
http://dx.doi.org/10.4103/0970-1591.30267
_version_ 1782170199693197312
author Nayyar, Rishi
Gupta, Narmada P.
author_facet Nayyar, Rishi
Gupta, Narmada P.
author_sort Nayyar, Rishi
collection PubMed
description Bisphosphonates are a relatively newer class of drugs which have been used for the prevention of skeletal related complications of age related osteoporosis or metastatic disease from carcinoma breast or multiple myeloma. Their role in the management of prostate cancer is still under evolution. We hereby review the ongoing and some published randomized trials to define the role of bisphosphonates in various stages of prostate cancer.
format Text
id pubmed-2721496
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-27214962009-08-12 Use of bisphosphonates in prostate cancer: Current status Nayyar, Rishi Gupta, Narmada P. Indian J Urol Symposium Bisphosphonates are a relatively newer class of drugs which have been used for the prevention of skeletal related complications of age related osteoporosis or metastatic disease from carcinoma breast or multiple myeloma. Their role in the management of prostate cancer is still under evolution. We hereby review the ongoing and some published randomized trials to define the role of bisphosphonates in various stages of prostate cancer. Medknow Publications 2007 /pmc/articles/PMC2721496/ /pubmed/19675763 http://dx.doi.org/10.4103/0970-1591.30267 Text en © Indian Journal of Urology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium
Nayyar, Rishi
Gupta, Narmada P.
Use of bisphosphonates in prostate cancer: Current status
title Use of bisphosphonates in prostate cancer: Current status
title_full Use of bisphosphonates in prostate cancer: Current status
title_fullStr Use of bisphosphonates in prostate cancer: Current status
title_full_unstemmed Use of bisphosphonates in prostate cancer: Current status
title_short Use of bisphosphonates in prostate cancer: Current status
title_sort use of bisphosphonates in prostate cancer: current status
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721496/
https://www.ncbi.nlm.nih.gov/pubmed/19675763
http://dx.doi.org/10.4103/0970-1591.30267
work_keys_str_mv AT nayyarrishi useofbisphosphonatesinprostatecancercurrentstatus
AT guptanarmadap useofbisphosphonatesinprostatecancercurrentstatus

Ejemplares similares